Cuantificación de esfingosina 1 fosfato en pacientes con periodontitis estadío II grado B

Autores/as

  • María I. García-Parra Department of Periodontics, Faculty of dentistry, Autonomous University of Yucatan (UADY), Mérida, YUC ZIP 97000, México Autor/a https://orcid.org/0000-0002-6712-0571
  • Matilde Jiménez-Coello Cellular Biology Laboratory, Regional Research Center “Dr. Hideyo Noguchi”, Autonomous University of Yucatan (UADY) Mérida, YUC ZIP 97000, México Autor/a https://orcid.org/0000-0002-8802-2049
  • Bertha A. Carrillo-Ávila Department of Periodontics, Faculty of dentistry, Autonomous University of Yucatan (UADY), Mérida, YUC ZIP 97000, México Autor/a https://orcid.org/0000-0001-5894-4459
  • Eduardo A. Sauri Esquivel Department of Periodontics, Faculty of dentistry, Autonomous University of Yucatan (UADY), Mérida, YUC ZIP 97000, México Autor/a https://orcid.org/0000-0001-8633-7103
  • Víctor M. Martínez-Aguilar Department of Periodontics, Faculty of dentistry. Cellular Biology Laboratory, Regional Research Center “Dr. Hideyo Noguchi” Autonomous University of Yucatan (UADY), Mérida, YUC ZIP 97000, México Autor/a https://orcid.org/0000-0003-2188-5293
  • Elda G. Chávez-Cortéz Faculty of Dentistry, Autonomous University of Baja California (UABC), Mexicali Campus, ZIP 21360, México Autor/a https://orcid.org/0000-0002-9566-2976

DOI:

https://doi.org/10.15517/ijds.2022.48877

Palabras clave:

Periodontitis; Esfingosina-1-fosfato; Osteoclastogénesis; Inflamación; Saliva; Líquido crevicular gingival.

Resumen

El propósito de este estudio fue la cuantificación de Esfingosina-1-Fosfato (S1P) en las bolsas periodontales de pacientes con periodontitis. Estudio observacional, descriptivo de casos y controles. 30 sujetos fueron seleccionados de los cuales 15 controles y 15 casos. Se realizó un estudio periodontal completo siguiendo los parámetros establecidos por la AAP en 2017 para el diagnóstico de las enfermedades periodontales. Se tomaron muestras de saliva y de líquido crevicular gingival de cada sujeto estudiado y se analizaron con el ELISA kit humano para S1P (MyBiosource #MBS2516132) y de acuerdo con las instrucciones del fabricante, se realizó para cuantificar la presencia d S1P en las muestras estudiadas. Los resultados mostraron diferencia significativa (p=0.05) entre casos y controles. En el caso de las muestras de saliva, la concentración de S1P en controles fue mayor (72.94 ng/mL y 45.12 ng/mL). Para Líquido crevicular gingival, se encontró mayor cantidad de S1P en los pacientes con periodontitis (20.09 ng/mL y 15.20 ng/mL). Este estudio plantea una posible ruta de metabolismo óseo, proceso inflamatorio e identificación de la Periodontitis a través de la cuantificación oral de S1P, sin embargo se necesitan estudios futuros.

Descargas

Los datos de descarga aún no están disponibles.

Referencias

Barbato L., Francioni E., Bianchi M., Mascitelli E., Brancato L., Tonelli D. Periodontitis and bone metabolism. Clin Cases in Miner Bone Metab. 2015; 12 (2): 174-177. DOI: https://doi.org/10.11138/ccmbm/2015.12.2.174

Hajishengallis G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat Rev Immunol. 2015; 15 (1): 30-44. DOI: https://doi.org/10.1038/nri3785

Baeza M., Garrido M., Hernandez-Rios P., Dezerega A., Garcıa-Sesnich J., Strauss F., Aitken J.P., Lesaffre E., Vanbelle S., Gamonal J., Brignardello-Petersen R., Tervahartiala T., Sorsa T, Hernandez M. Diagnostic accuracy for apical and chronic periodontitis biomarkers in gingival crevicular fluid: an exploratory study. J Clin Periodontol. 2016; 43 (1): 34-45 DOI: https://doi.org/10.1111/jcpe.12479

Bostanci N., Belibasakis G. Gingival crevicular fluid and its immune mediators in the proteomic era. Periodontol 2000. 2018; 76 (1): 68-84. DOI: https://doi.org/10.1111/prd.12154

Suchetha A., Shahna N., Sapna N., Darshan B., Apoorva S., Bhat D. Gingival crevicular fluid: A Review of literature. Annals of Dental Specialty. 2018; 6 (2): 211-216.

Duvina M., Barbato L., Brancato L., Delle Rose G., Amunni F., Tonelli P. Biochemical markers as predictors of bone remodelling in dental disorders: a narrative description of literature. Clin cases in Miner Bone Metab. 2012; 9 (2): 100-106.

Taubman M., Valverde P., Han X., Kawai T. Immune Response: The Key to Bone Resorption in Periodontal Disease. J Periodontol. 2005; 76 (11): 2033-2041. DOI: https://doi.org/10.1902/jop.2005.76.11-S.2033

Naruishi K., Nagata T. Biological effects of interleukin 6 on Gingival Fibroblasts: Cytokine regulation in periodontitis. J Cell Physiol. 2018; 233 (9): 6393-400. DOI: https://doi.org/10.1002/jcp.26521

Wright H., McCarthy H.S., Middleton J., Marshall M. RANK, RANKL and osteoprotegerin in bone biology and disease. Curr Rev Musculoskelet Med. 2009; 2 (1): 56-64. DOI: https://doi.org/10.1007/s12178-009-9046-7

Nagasawa T., Kiji M., Yashiro R., Hormdee D., Lu H., Kunze M., Suda T., Koshy G., Kobayashi H., Oda S., Nitta H., Ishikawa, I. Roles of receptor activator of nuclear factor κB ligand (RANKL) and osteoprotegerin in periodontal health and disease. Periodontol 2000. 2007; 43 (1): 65-84. DOI: https://doi.org/10.1111/j.1600-0757.2006.00185.x

Kapasa E., Giannoudis P., Jia X., Yang X. The effect of rankl/opg balance on reducing implant complications. J Funct Biomater. 2017; 8 (4): 42:2-10. DOI: https://doi.org/10.3390/jfb8040042

Reynolds G.M., Visentin B., Sabbadini R. Immunohistochemical Detection of Sphingosine-1-Phosphate and Sphingosine Kinase-1 in Human Tissue Samples and Cell Lines. Methods Mol Biol. 2018; 1697: 43-56. DOI: https://doi.org/10.1007/7651_2017_44

Meshcheryakova A., Mechtcheriakova D., Pietschmann P. Sphingosine 1-phosphate signaling in bone remodeling: Multifaceted roles and therapeutic potential. Expert Opin Ther Targets.2017; 21 (7): 725-737. DOI: https://doi.org/10.1080/14728222.2017.1332180

Xiao L., Zhou Y., Friis T., Beagley K. and Xiao Y. S1P-S1PR1 Signaling: the “Sphinx” in Osteoimmunology. Front. Immunol. 2019; 10: 1409:1-18. DOI: https://doi.org/10.3389/fimmu.2019.01409

Ishii M., & Kikuta J. Sphingosine-1-phosphate signaling controlling osteoclasts and bone homeostasis. Biochim Biophys Acta. 2013; 1831 (1): 223-227. DOI: https://doi.org/10.1016/j.bbalip.2012.06.002

Yu H., Sun C., Argraves K. Periodontal inflammation and alveolar bone loss induced by Aggregatibacter actinomycetemcomitans is attenuated in sphingosine kinase 1- deficient mice. J Periodont Res. 2016; 51 (1): 38-49. DOI: https://doi.org/10.1111/jre.12276

Ishii M., Egen J.G., Klauschen F., Meier-Schellersheim M., Saeki, Y., Vacher J., Germain R.N. Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis. Nature. 2009; 458 (7237): 524-528. DOI: https://doi.org/10.1038/nature07713

Ishii M., Shimazu Y., Meier-Schellersheim M., Germain R. Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and bone remodeling invivo. J Exp Med. 2010; 207 (13): 2793-2798. DOI: https://doi.org/10.1084/jem.20101474

Aoki M., Aoki H., Ramanathan R., C. Hait N., Takabe K. Sphingosine-1-Phosphate Signaling in Immune Cells and Inflammation: Roles and Therapeutic Potential. Mediators of Inflamm. 2016; 2016: 1-11. DOI: https://doi.org/10.1155/2016/8606878

Maceyka M., Harikumar K., Milstien S., Spiegel S. Sphingosine-1-phosphate signaling and its role in disease. Trends Cell Biol. 2012; 22 (1): 50-60. DOI: https://doi.org/10.1016/j.tcb.2011.09.003

Caton, J., Armitage, G., Berglundh, T., et al. A new classification scheme for periodontal and peri-implant diseases and conditions- Introduction and key changes from the 1999 classification. J Clin Periodontol. 2018; 45 (20): S1-S8. DOI: https://doi.org/10.1111/jcpe.12935

Dame Z., Aziat F., Mandal R., Krishnamurthy R,1Bouatra S, Borzoui S, et al. The Human Saliva Metabolome. Metabolomics. 2015; 11 (1): 864-83. DOI: https://doi.org/10.1007/s11306-015-0840-5

Leppilahti, J.M., Hernández-Ríos, P.A., Gamonal, J.A., Tervahartiala, T., Brignardello-Petersen, R, Mantyla, P, Sorsa, T, Hernández, M. Matrix metalloproteinases and myeloperoxidase in gingival crevicular fluid provide site-specific diagnostic value for chronic periodontitis. J Clin Periodontol. 2014; 41: 348-356. DOI: https://doi.org/10.1111/jcpe.12223

Gamonal J., Bascones A., Jorge O., Silva A. Chemokine RANTES in gingival crevicular fluid of Adult patients with periodontitis. J Clin Periodontol. 2000; 27: 675-681. DOI: https://doi.org/10.1034/j.1600-051x.2000.027009675.x

Navazesh, M. Methods for collecting saliva. Ann Ny Acad Sci. 1993; 694 (1): 72-77. DOI: https://doi.org/10.1111/j.1749-6632.1993.tb18343.x

Spring Bio Science. Phosphate Buffered Saline with Tween 20 (20x). California. 2012.

World Health Organization. Obesity and overweight. OMS April 2020. URL: https://www.who.int/es/news-room/fact-sheets/detail/obesity-and-overweight. Accessed May 2020.

Sartawi Z., Schipani E., Ryan K., Waeber C. Sphingosine 1-phosphate (S1P) signalling: Role in bone biology and potential therapeutic target for bone repair. Pharmacol Res. 2017; 125: 232-245. DOI: https://doi.org/10.1016/j.phrs.2017.08.013

Hutami I., Tanaka E., Izawa T. Crosstalk between Fas and S1P1 signaling via NF-kB in osteoclasts controls bone destruction in the TMJ due to rheumatoid arthritis. Jpn Dent Sci Rev. 2019: 55 (1):12-19. DOI: https://doi.org/10.1016/j.jdsr.2018.09.004

Obinata H., Hla T. Sphingosine 1-phosphate and inflammation. Int immunol. 2019; 31 (9): 617-625. DOI: https://doi.org/10.1093/intimm/dxz037

Proia R., Hla T. Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy. J Clin Invest. 2015; 125 (4): 1379-1387. DOI: https://doi.org/10.1172/JCI76369

Xiao Y., Wu J., Yuan Y., Guo X., Chen B., Huang Q. Effect of moesin phosphorylation on high-dose sphingosine-1-phosphate-induced endothelial responses. Mol Med Rep. 2018; 17 (1): 1933-1939. DOI: https://doi.org/10.3892/mmr.2017.8029

Keller J., Catala-Lehnen P., Huebner A., Jeschke A., Heckt T., Lueth A., Schilling S., et. al. Calcitonin controls bone formation by inhibiting the release of sphingosine 1- phosphate from osteoclasts. Nat Commun. 2014; 5: 5215:1-13. DOI: https://doi.org/10.1038/ncomms6215

Khavandgar Z., Murshed M. Sphingolipid metabolism and its role in the skeletal tissues. Cell Mol Life Sci. 2015; 72 (5): 959-969. DOI: https://doi.org/10.1007/s00018-014-1778-x

Barembaum S., Azcurra A. La saliva: una potencial herramienta en la Odontología. Rev Fac Odont. 2019; 29 (2): 9-21. DOI: https://doi.org/10.25014/revfacodont271.2019.2.9

Koss M., Castro C., Salúm K., López M. Changes in saliva protein composition in patients with periodontal disease. Acta Odontológica Latinoamericana. 2009; 22 (2): 105-112.

Gohda M., Kunisawa J., Miura F., Kagiyama Y., Kurashima Y., Higuchi, M., et al. Sphingosine 1-phosphate regulates the egress of IgA plasmablasts from Peyer’s patches for intestinal IgA responses. J Immunol. 2008; 180 (8): 5335- 5343. DOI: https://doi.org/10.4049/jimmunol.180.8.5335

Publicado

2026-06-15